
Tissue & inflammation
TB-500 (Thymosin β-4)
Thymosin β-4 active fragment
Overview
Thymosin β-4 active fragment
A synthetic fragment corresponding to the actin-binding domain of thymosin beta-4. Supplied lyophilized for in-vitro study of actin sequestration, cell migration and angiogenesis assays.
- Fill: 10 mg / vial
- Pack: 1 vial · 10 mg total
- Purity: ≥99%
For in-vitro laboratory research use only. Not for human or animal consumption, medical, diagnostic or therapeutic use.
Receptor pharmacology
Binds G-actin, regulates cytoskeletal remodeling, upregulates anti-inflammatory pathways, promotes VEGF-mediated angiogenesis and endothelial cell migration.
Laboratory handling
Research use disclaimer
Sacred Peptides does not provide dosing recommendations for human use. TB-500 (Thymosin β-4) is supplied for in-vitro laboratory research only. Any concentration ranges referenced on this page or in cited studies describe the parameters used in that research and are not instructions.
- Not a drug. Not approved by Health Canada or the FDA for human use.
- Not intended to diagnose, treat, cure, or prevent any disease.
- Not for use in humans, pregnant or nursing individuals, or animals outside a controlled research setting.
- Handling, storage, and disposal are the responsibility of a qualified researcher.